GoodRx Holdings, Inc. (GDRX)
2.76
0.00 (0.00%)
USD |
NASDAQ |
Dec 17, 15:37
GoodRx Holdings Research and Development Expense (Annual): 123.75M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Spok Holdings, Inc. | 11.55M |
| DarioHealth Corp. | 24.18M |
| National Research Corp. | -- |
| Axe Compute, Inc. | 0.026M |
| Certara, Inc. | 37.10M |